New Jersey Transit would stock southern light-rail trains with overdose antidotes

New Jersey Transit would run a two-year pilot supplying opioid antidotes on each southern New Jersey light-rail train set. The pilot would cover every light-rail train set operating in the southern part of New Jersey. The corporation would choose the adequate types and amounts with the Department of Health, and would consult the Deputy Commissioner for Public Health Services when setting up the program. Each train would have a secure, accessible location with at least two doses, a silent alert to the operator, and signs and cards in English and Spanish. Staff would check and maintain the supplies and keep records. They would not have to give the antidote or receive special training; an alert would require the operator to contact emergency services at the nearest station. The $100,000 General Fund appropriation would help cover implementation costs. The act would take effect on the first day of the sixth month after enactment. The pilot would last two years, and the act would expire when the required report is submitted; that report is due within six months after the pilot ends.